Ionis Pharmaceuticals Inc’s recent filing unveils that its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for reported $39046.0 on Feb 20 ’25. In the deal valued at $32.35 per share,1,207 shares were sold. As a result of this transaction, O’NEIL PATRICK R. now holds 56,245 shares worth roughly $1.83 million.
Then, O’NEIL PATRICK R. sold 6,165 shares, generating $194,939 in total proceeds. Upon selling the shares at $31.62, the EVP CLO & General Counsel now owns 57,452 shares.
Before that, Monia Brett P sold 38,843 shares. Ionis Pharmaceuticals Inc shares valued at $1,229,463 were divested by the Chief Executive Officer at a price of $31.65 per share. As a result of the transaction, Monia Brett P now holds 180,683 shares, worth roughly $5.89 million.
BMO Capital Markets downgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Market perform from a an Outperform in a research note published on August 02, 2024; the price target was decreased to $60 from $67. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late July from “a Market perform” to “an Outperform”. Bernstein revised its rating on June 14, 2024. It rated IONS as “a Mkt perform” which previously was an “an Underperform”.
Price Performance Review of IONS
On Monday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -1.78% to $32.60. Over the last five days, the stock has gained 2.23%. Ionis Pharmaceuticals Inc shares have fallen nearly -6.75% since the year began. Nevertheless, the stocks have fallen -29.95% over the past one year. While a 52-week high of $52.34 was reached on 01/02/25, a 52-week low of $30.23 was recorded on 02/13/25. SMA at 50 days reached $33.38, while 200 days put it at $39.84.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 32.05, which if violated will result in even more drops to 31.51. On the upside, there is a resistance level at 33.34. A further resistance level may holdings at 34.09. The Relative Strength Index (RSI) on the 14-day chart is 50.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.45%. Stochastics %K at 47.67% indicates the stock is a holding.
